bar
Pennsylvania Department of Drug & Alcohol Programs
Inspection Results

bar

Surveys don't appear on this website until at least 41 days have elapsed since the exit date of the survey.

WPIC NARCOTIC ADDICTION TREATMENT PROGRAM
225 PENN AVENUE
PITTSBURGH, PA 15221

Inspection Results   Overview    Definitions       Surveys   Additional Services   Search

Survey conducted on 07/26/2012

INITIAL COMMENTS
 
This report is a result of an on-site inspection conducted for the approval to use a narcotic agent, specifically methadone, in the treatment of narcotic addiction. This inspection was conducted on July 24-26, 2012 by staff from the Division of Drug and Alcohol Program Licensure. Based on the findings of the on-site inspection, WPIC Narcotic Addiction Treatment Program was found not to be in compliance with the applicable chapters of 4 PA Code and 28 PA Code which pertain to the facility. The following deficiencies were identified during this inspection.
 
Plan of Correction

715.17(c)(1)(i-vi))  LICENSURE Medication control

(c) A narcotic treatment program shall develop and implement written policies and procedures regarding the medications used by patients which shall include, at a minimum: (1) Administration of medication. (i) A narcotic treatment physician shall determine the patient 's initial and subsequent dose and schedule. The physician shall communicate the initial and subsequent dose and schedule to the person responsible for the administration of medication. Each medication order and dosage change shall be written and signed by the narcotic treatment physician. (ii) An agent shall be administered or dispensed only by a practitioner licensed under the appropriate Federal and State laws to dispense agents to patients. (iii) Only authorized staff and patients who are receiving medication shall be permitted in the dispensing area. (iv) There shall be only one patient permitted at a dispensing station at any given time. (v) Each patient shall be observed when ingesting the agent. (vi) Administering and dispensing shall be conducted in a manner that protects the patient from disruption or annoyance from other individuals.
Observations
Based on a review of patient records, the facility failed to ensure that the narcotic treatment physician determined dose changes in accordance with the regulations and facility policy in five of eleven patient records.



The findings include:



Twenty patient records were reviewed on July 24-26, 2012. Eleven patient records were reviewed for the physician's documentation in determining the initial and subsequent dose of methadone. These records revealed that the physician was making determinations of incremental increases without direct assessment of the patient. The facility did not document that the narcotic treatment physician determined the proper dosage level in patient records # 2, 6, 7, 8 and 13.



Patient #2 received an initial dose on May 7, 2012. Documented in patient record #2 was an order by the physician dated May 15, 2012 that included a standing order to increase the patient dosage 5 mg daily for the next two days to 40 mg. Another order dated May 17, 2012 included a standing order to increase the patient dosage 5 mg daily for the next two days to 50 mg. There was no documentation that the narcotic treatment physician continued to assess the patient to determine if an increase in the patient's dose was needed.



Patient #6 received an initial dose on March 8, 2012. Documented in patient record #6 was an order by the physician dated April 13, 2012 that included a standing order to increase the patient dosage 5 mg daily for the next two days to 60 mg. Another order dated May 7, 2012 included a standing order to increase the patient dosage 5 mg daily for the next three days to 80 mg. There was no documentation that the narcotic treatment physician continued to assess the patient to determine if an increase in the patient's dose was needed.



Patient #7 received an initial dose on April 30, 2012. Documented in patient record #7 was an order by the physician dated May 2, 2012 that included a standing order to increase the patient dosage 5 mg daily for the next two days to 40 mg. A subsequent order dated May 7, 2012 included a standing order to increase the patient dosage 5 mg daily for the next three days to 55 mg. Another order dated May 14, 2012 included a standing order to increase the patient dosage 5 mg daily for the next two days to 65 mg. Lastly, an order dated May 21, 2012 included a standing order to increase the patient dosage 5 mg daily for the next two days to 75 mg. There was no documentation that the narcotic treatment physician continued to assess the patient to determine if an increase in the patient's dose was needed.



Patient #8 received an initial dose on June 6, 2012. Documented in patient record #8 was an order by the physician dated June 11, 2012 that included a standing order to increase the patient dosage 5 mg daily for the next two days to 45 mg. There was no documentation that the narcotic treatment physician continued to assess the patient to determine if an increase in the patient's dose was needed.



Patient #13 received an initial dose on January 11, 2012. Documented in patient record #13 was an order by the physician dated January 17, 2012 that included a standing order to increase the patient dosage 5 mg daily for the next two days to 40 mg. There was no documentation that the narcotic treatment physician continued to assess the patient to determine if an increase in the patient's dose was needed.



An interview with the nurse manager took place on July 26, 2012. The findings were not disputed and there was no further documentation provided.
 
Plan of Correction
Under the direction of the clinical administrator or her designee, NATP physicians will be trained by the Medical Director by 9/1/12 on: the requirement to determine the initial and subsequent dose changes of methadone via direct assessment of the patient each time there is a medication dose change; documentation in the patient clinical record that the narcotic treatment physician continued to assess the patient to determine if an increase in the patient's dose was needed; each order must be written, timed and dated by the physician. Clinical nurses will monitor compliance via auditing 10 charts per month for 4 months beginning with the month of September 2012 and ending with the month of December 2012. The results of the monthly chart audits will be shared with the NATP Physicians and program leadership.

 
Pennsylvania Department of Drug and Alcohol Programs Home Page


Copyright @ 2001 Commonwealth of Pennsylvania. All Rights Reserved.
Commonwealth of PA Privacy Statement